REGENXBIO to Participate in Upcoming Investor Conferences
REGENXBIO (Nasdaq: RGNX) has announced its participation in four major upcoming investor conferences in September 2025. The company will attend the Wells Fargo Healthcare Conference for one-on-one meetings in Boston on September 4, followed by three fireside chat presentations in New York: the Morgan Stanley Global Healthcare Conference on September 8, and both the Baird Global Healthcare Conference and H.C. Wainwright Global Investment Conference on September 9.
Select fireside chat presentations will be available via webcast through REGENXBIO's investor relations website, with recordings accessible for approximately 30 days after each event.
REGENXBIO (Nasdaq: RGNX) ha comunicato la sua partecipazione a quattro importanti conferenze per investitori a settembre 2025. La societ脿 sar脿 al Wells Fargo Healthcare Conference per incontri one-to-one a Boston il 4 settembre, per poi tenere tre interventi in forma di fireside chat a New York: il Morgan Stanley Global Healthcare Conference l'8 settembre e sia il Baird Global Healthcare Conference sia l'H.C. Wainwright Global Investment Conference il 9 settembre.
Alcune fireside chat saranno trasmesse in webcast tramite il sito delle relazioni con gli investitori di REGENXBIO; le registrazioni saranno disponibili per circa 30 giorni dopo ciascun evento.
REGENXBIO (Nasdaq: RGNX) ha anunciado su participaci贸n en cuatro importantes conferencias para inversores en septiembre de 2025. La compa帽铆a asistir谩 al Wells Fargo Healthcare Conference para reuniones individuales en Boston el 4 de septiembre, y ofrecer谩 tres charlas tipo fireside en Nueva York: el Morgan Stanley Global Healthcare Conference el 8 de septiembre, y tanto el Baird Global Healthcare Conference como el H.C. Wainwright Global Investment Conference el 9 de septiembre.
Algunas de las fireside chat estar谩n disponibles por webcast a trav茅s del sitio web de relaciones con inversores de REGENXBIO; las grabaciones podr谩n consultarse durante aproximadamente 30 d铆as tras cada evento.
REGENXBIO (Nasdaq: RGNX)電� 2025雲� 9鞗旍棎 鞐措Μ電� 雱� 瓯挫潣 欤检殧 韴瀽鞛� 旎嵓霟办姢鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 9鞗� 4鞚� 氤挫姢韯挫棎靹� 鞐措Μ電� Wells Fargo Healthcare Conference鞐愳劀 鞚茧寑鞚� 氙疙寘鞚� 歆勴枆頃� 霋�, 雺挫殨鞐愳劀 靹� 彀鞚� 韺岇澊鞏挫偓鞚措摐 毂勴寘鞚� 歆勴枆頃╇媹雼�: 9鞗� 8鞚� Morgan Stanley Global Healthcare Conference, 攴鸽Μ瓿� 9鞗� 9鞚� Baird Global Healthcare Conference鞕赌 H.C. Wainwright Global Investment Conference鞛呺媹雼�.
鞚茧秬 韺岇澊鞏挫偓鞚措摐 毂勴寘鞚� REGENXBIO 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 鞗轨簮鞀ろ姼搿� 鞝滉车霅橂┌, 臧� 頄夓偓 頉� 鞎� 30鞚� 霃欖晥 雲鬼檾 鞓侅儊鞚� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
REGENXBIO (Nasdaq: RGNX) a annonc茅 sa participation 脿 quatre grandes conf茅rences investisseurs en septembre 2025. La soci茅t茅 assistera au Wells Fargo Healthcare Conference pour des rencontres individuelles 脿 Boston le 4 septembre, puis tiendra trois 芦 fireside chats 禄 脿 New York听: le Morgan Stanley Global Healthcare Conference le 8 septembre, ainsi que le Baird Global Healthcare Conference et le H.C. Wainwright Global Investment Conference le 9 septembre.
Certaines pr茅sentations en fireside chat seront diffus茅es en webcast via le site relations investisseurs de REGENXBIO听; les enregistrements resteront accessibles environ 30 jours apr猫s chaque 茅v茅nement.
REGENXBIO (Nasdaq: RGNX) hat seine Teilnahme an vier wichtigen Investorenkonferenzen im September 2025 angek眉ndigt. Das Unternehmen wird am 4. September f眉r Einzelgespr盲che auf der Wells Fargo Healthcare Conference in Boston vertreten sein und anschlie脽end in New York drei Fireside-Chats halten: am 8. September beim Morgan Stanley Global Healthcare Conference sowie am 9. September beim Baird Global Healthcare Conference und dem H.C. Wainwright Global Investment Conference.
Ausgew盲hlte Fireside-Chats werden per Webcast 眉ber die Investor-Relations-Website von REGENXBIO verf眉gbar sein; Aufzeichnungen sind etwa 30 Tage nach den jeweiligen Veranstaltungen abrufbar.
- None.
- None.
2025 Wells Fargo Healthcare Conference
1x1 Investor Meetings: Thursday, September 4
尝辞肠补迟颈辞苍:听
Morgan Stanley 23rd Annual Global Healthcare Conference
Fireside Chat:听Monday, September 8, 2025 at 11:30 a.m. ET
尝辞肠补迟颈辞苍:听
Baird 2025 Global Healthcare Conference
Fireside Chat: Tuesday, September 9, 2025 at 8:30 a.m. ET
Location:
H.C. Wainwright 27th Annual Global Investment Conference
Fireside Chat: Tuesday, September 9, 2025 at 2:30 p.m. ET
Location:
Live webcasts of select fireside chats can be accessed in the Investors section of REGENXBIO's website at . An archived replay of the webcast will be available for approximately 30 days following the presentation.
ABOUT REGENXBIO Inc.
REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field of AAV gene therapy. REGENXBIO is advancing a late-stage pipeline of one-time treatments for rare and retinal diseases, including RGX-202 for the treatment of Duchenne; clemidsogene lanparvovec (RGX-121) for the treatment of MPS II and RGX-111 for the treatment of MPS I, both in partnership with Nippon Shinyaku; and surabgene lomparvovec (ABBV-RGX-314) for the treatment of wet AMD and diabetic retinopathy, in collaboration with AbbVie. Thousands of patients have been treated with REGENXBIO's AAV platform, including those receiving Novartis' ZOLGENSMA庐. REGENXBIO's investigational gene therapies have the potential to change the way healthcare is delivered for millions of people. For more information, please visit .
Contacts:
Dana Cormack
Corporate Communications
[email protected]听
Investors:
George E. MacDougall
Investor Relations
[email protected]听
听
View original content to download multimedia:
SOURCE REGENXBIO Inc.
FAQ
When is REGENXBIO (RGNX) presenting at the Morgan Stanley Healthcare Conference 2025?
How can I watch REGENXBIO's (RGNX) investor conference presentations?
Which investor conferences is REGENXBIO (RGNX) attending in September 2025?
Where will REGENXBIO's (RGNX) September 2025 investor conferences take place?
